EnsiliTech, the award-winning biopharmaceuticals company has raised £1.2 million in pre-seed funding to aid the development of a pioneering refrigeration-free approach to transporting vaccines and other materials.

EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing biologicals such as vaccines, antibody treatments, or even insulin.